Studies involving cancer patients undergoing anticancer therapies revealed that those patients who gained weight exhibited increased IL-15 values at 4 and 8 weeks during treatment, compared to both their baseline levels and patients who lost weight [195]. This evidence concerns the gene IL15 and cancer.